Exchange: NASDAQ·Updated 10:39 AM EDT

About ANEB

About

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Anebulo Pharmaceuticals Inc?
What is the 52-week high for Anebulo Pharmaceuticals Inc?
What is the 52-week low for Anebulo Pharmaceuticals Inc?
What is Anebulo Pharmaceuticals Inc stock price today?
What was Anebulo Pharmaceuticals Inc stock price yesterday?
What is the Price-to-Book ratio of Anebulo Pharmaceuticals Inc?
What is the 50-day moving average of Anebulo Pharmaceuticals Inc?

Advertisement|Remove ads.